Finzati - Logo
DCTH logo

Delcath Systems, Inc.

DCTH • Medical - Devices
$16.48
— 0.00 (0.00%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$655.27M
Growth
—
Cash Flow
1/5
Trend
Volatile
Evidence
Positive revenue growth · 47.9%Positive free cash flow · 0.59Manageable debt level · 0.01Healthy liquidity · 10.92Expensive earnings multiple · 134
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:26 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$16.48
Change0.00%
Shares Out39.76M
Market Cap$655.27M
Enterprise Value$561.83M
52W Range8.12 - 15.62
Beta0.49
P/E1,231.71
P/S6.87
P/B5.41
P/FCF36.83
EV/Sales5.89

Investment DNA

How strong this company looks for long-term investors

58
out of 100
Business Quality
Margins, moat, returns
40/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
53/100
Why this score▼
Positive revenue growth · 47.9%Positive free cash flow · 0.59Manageable debt level · 0.01Healthy liquidity · 10.92Expensive earnings multiple · 134

Analyst view

Analyst sentiment and price target

DCTH
Analyst sentiment
Based on 11 analyst votes · 2026-09-05
82/100
Bullish
Bullish
8
Hold
2
Bearish
1
Price Target
2026-08-07
Low
$17.00
Mean
$25.33
Median
$27.00
High
$32.00

Company Overview

IPO: 5/3/2018
Industry: Medical - Devices
P/B i: 5.41
Debt / Equity i: 0.01
Operating Margin: 0.77%
Net Margin: 3.17%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.01
Current Ratio: 10.92
Quick Ratio: 9.98
Status: Good

Insider Transactions

Recent executive and insider activity

Aharon Gil
Transaction: 05/13/2026
BUY
Change
+22,500
Price
$11.61
Filing
05/14/2026
Type
BUY
SALAMON STEVEN A J
Transaction: 05/13/2026
BUY
Change
+22,500
Price
$11.61
Filing
05/14/2026
Type
BUY
CZEREPAK ELIZABETH
Transaction: 05/13/2026
BUY
Change
+22,500
Price
$11.61
Filing
05/14/2026
Type
BUY